Study Shows Sandoz Biosimilar Equivalent to Originator Drug

News   Jul 12, 2016

 
Study Shows Sandoz Biosimilar Equivalent to Originator Drug
 
 
 

RELATED ARTICLES

Empowering Women in Technology Key to Boosting UK Economy

News

A new report launched at London Stock Exchange for International Women’s Day, reveals the critical role women play in driving economic growth across the UK, with detailed research on 1,279 women-led companies showing a total contribution of £25.9 billion in revenue to the UK economy.

READ MORE

New Strategy Against Vascular Disease in Diabetes?

News

Recent findings suggest a novel approach for protecting people with diabetes from their higher risk of advanced blood vessel disease, which sets the stage for early heart attacks and strokes.

READ MORE

Could Daffodils Help Treat Cancer?

News

A new study describes the anti-cancer effects of a natural alkaloid extracted from Daffodils. The researchers have discovered that this compound triggers the activation of an anti-tumoral surveillance pathway.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE